Health-related quality of life in the ENDEAVOR study : carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma

DSpace Repository

Show simple item record

dc.contributor.author Weisel, Katja
dc.date.accessioned 2020-06-09T08:23:44Z
dc.date.available 2020-06-09T08:23:44Z
dc.date.issued 2019
dc.identifier.issn 2044-5385
dc.identifier.uri http://hdl.handle.net/10900/101381
dc.language.iso en de_DE
dc.publisher Nature Publishing Group de_DE
dc.relation.uri http://dx.doi.org/10.1038/s41408-019-0181-0 de_DE
dc.subject.ddc 610 de_DE
dc.title Health-related quality of life in the ENDEAVOR study : carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma de_DE
dc.type Artikel de_DE
utue.quellen.id 20190926111821_02521
utue.personen.roh Ludwig, Heinz
utue.personen.roh Moreau, Philippe
utue.personen.roh Dimopoulos, Meletios A.
utue.personen.roh Mateos, Maria-Victoria
utue.personen.roh Kaiser, Martin
utue.personen.roh Hajek, Roman
utue.personen.roh Feng, Shibao
utue.personen.roh Cocks, Kim
utue.personen.roh Buchanan, Jaqueline
utue.personen.roh Weisel, Katja
dcterms.isPartOf.ZSTitelID Blood Cancer Journal de_DE
dcterms.isPartOf.ZS-Issue Article 23 de_DE
dcterms.isPartOf.ZS-Volume 9 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record